Elizabeth Hughes, DO
Family Medicine · Traverse City, MINPI 1811943723
Payments from drug & device makers
Across 99 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$205
- Novo Nordisk$205
- Pfizer$174
- Astellas Pharma US Inc$163
- AstraZeneca$135
- GSK$86
- plus $764 from 24 others
What the payments were for
- Food & beverage$1,731100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $205 |
| Novo Nordisk | 12 | $205 |
| Pfizer | 10 | $174 |
| Astellas Pharma US Inc | 8 | $163 |
| AstraZeneca | 9 | $135 |
| GSK | 5 | $86 |
| Amgen | 5 | $85 |
| Lilly USA, LLC | 5 | $80 |
| Bayer | 5 | $76 |
| Exact Sciences | 3 | $63 |
| Actelion Pharmaceuticals US, Inc. | 2 | $46 |
| Boehringer Ingelheim | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Merck | 2 | $25 |
| Johnson & Johnson | 2 | $25 |
| Corium, LLC | 1 | $22 |
| Biogen | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Baxter Healthcare | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
How this compares
$1,731 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 52 | $69,278 |
| JardianceEmpagliflozin | 44 | $56,666 |
| OzempicSemaglutide | 34 | $56,176 |
| TrulicityDulaglutide | 26 | $49,919 |
| XareltoRivaroxaban | 15 | $23,192 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $19,868 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $10,508 |
| Atrovent HfaIpratropium Bromide | 13 | $6,695 |
| Atorvastatin Calcium | 396 | $6,095 |
| Levothyroxine Sodium | 365 | $5,368 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $5,036 |
| Estradiol | 55 | $4,298 |
| Bupropion XlBupropion Hcl | 99 | $3,903 |
| Losartan Potassium | 262 | $3,524 |
| Metoprolol Succinate | 169 | $2,735 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $174 | $69,27852 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $45 | $61,70255 claims |
| Novo NordiskOzempic | $205 | $56,17634 claims |
| Lilly USA, LLCTrulicity | $80 | $49,91926 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $86 | $30,37630 claims |
| Johnson & JohnsonXarelto | $25 | $23,19215 claims |
| AbbVieSynthroid | $205 | $2,05123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Traverse City
- Rafay BaigTraverse City$48K
- Kathryn ShafferTraverse City$20K
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.